Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon M Bates

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Blood|May 1, 2015
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort studyLori-Ann Linkins, Shannon M Bates, Agnes Y Y Lee, et al.
American Journal of Hematology|September 23, 2008
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxisKhalid A Alsaleh, Sami M A Al-Nasser, Shannon M Bates, et al.
Thrombosis Research|July 10, 2017
Management of hereditary antithrombin deficiency in pregnancyAndra H James, Shannon M Bates, Kenneth A Bauer, et al.
Archives of Internal Medicine|September 15, 2010
A population-based study of inferior vena cava filters in patients with acute venous thromboembolismFrederick A Spencer, Shannon M Bates, Robert J Goldberg, et al.
Annals of Internal Medicine|March 14, 2012
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysisIgnacio Neumann, Gabriel Rada, Juan Carlos Claro, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physiciansJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
The Annals of Pharmacotherapy|May 26, 2005
Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trialsJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
Annals of Internal Medicine|May 21, 2003
A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosisShannon M Bates, Clive Kearon, Mark Crowther, et al.
Thrombosis Research|February 5, 2003
Low-dose warfarin in rehabilitating stroke survivorsJeffrey S Ginsberg, Shannon M Bates, Wieslaw Oczkowski, et al.
Annals of Internal Medicine|April 6, 2005
A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonographyClive Kearon, Jeffrey S Ginsberg, James Douketis, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Blood|May 1, 2015
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort studyLori-Ann Linkins, Shannon M Bates, Agnes Y Y Lee, et al.
American Journal of Hematology|September 23, 2008
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxisKhalid A Alsaleh, Sami M A Al-Nasser, Shannon M Bates, et al.
Thrombosis Research|July 10, 2017
Management of hereditary antithrombin deficiency in pregnancyAndra H James, Shannon M Bates, Kenneth A Bauer, et al.
Archives of Internal Medicine|September 15, 2010
A population-based study of inferior vena cava filters in patients with acute venous thromboembolismFrederick A Spencer, Shannon M Bates, Robert J Goldberg, et al.
Annals of Internal Medicine|March 14, 2012
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysisIgnacio Neumann, Gabriel Rada, Juan Carlos Claro, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physiciansJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
The Annals of Pharmacotherapy|May 26, 2005
Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trialsJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
Annals of Internal Medicine|May 21, 2003
A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosisShannon M Bates, Clive Kearon, Mark Crowther, et al.
Thrombosis Research|February 5, 2003
Low-dose warfarin in rehabilitating stroke survivorsJeffrey S Ginsberg, Shannon M Bates, Wieslaw Oczkowski, et al.
Annals of Internal Medicine|April 6, 2005
A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonographyClive Kearon, Jeffrey S Ginsberg, James Douketis, et al.
Pageof 10